VSGIX
Price
$100.96
Change
+$0.70 (+0.70%)
Updated
Aug 21 closing price
Net Assets
43.86B
YOVLX
Price
$17.01
Change
+$0.18 (+1.07%)
Updated
Aug 21 closing price
Net Assets
36.56M
Interact to see
Advertisement

VSGIX vs YOVLX

VSGIX vs YOVLX Comparison Chart in %
View a ticker or compare two or three
VS
VSGIX vs. YOVLX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSGIX is a Buy and YOVLX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGIX has more cash in the bank: 43.9B vs. YOVLX (36.6M). VSGIX pays higher dividends than YOVLX: VSGIX (0.45) vs YOVLX (0.00). VSGIX was incepted earlier than YOVLX: VSGIX (26 years) vs YOVLX (10 years). YOVLX (2.76) is less costly to investors than VSGIX (0.05). YOVLX is a more actively managed with annual turnover of: 81.00 vs. VSGIX (24.00). YOVLX has a lower initial minimum investment than VSGIX: YOVLX (1000) vs VSGIX (5000000). VSGIX annual gain was more profitable for investors over the last year : 26.41 vs. YOVLX (7.05). VSGIX return over 5 years is better than : 29.94 vs. YOVLX (-2.69).
VSGIXYOVLXVSGIX / YOVLX
Total Expense Ratio0.052.352%
Annual Report Gross Expense Ratio0.052.762%
Fund Existence26 years10 years-
Gain YTD18.8797.931238%
Front LoadN/AN/A-
Min. Initial Investment50000001000500,000%
Min. Initial Investment IRAN/AN/A-
Net Assets43.9B36.6M119,945%
Annual Yield % from dividends0.450.00-
Returns for 1 year26.417.05375%
Returns for 3 years62.7831.35200%
Returns for 5 years29.94-2.69-1,113%
Returns for 10 years176.3255.91315%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGHFX49.030.59
+1.22%
Hartford Healthcare F
HSWRX24.200.28
+1.17%
Hartford Schroders International Stk R3
WCMVX23.700.23
+0.98%
WCM Focused International Equity Ins
VOLMX26.550.19
+0.72%
Volumetric
NDVIX18.860.06
+0.32%
MFS New Discovery Value I